Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2011

4001 ARTíCULOS , VIENDO DEL 31 AL 45

PUBMED

Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease.

Nobili F, Arnaldi D, Campus C, Ferrara M, De Carli F, Brugnolo A, Dessi B, Girtler N, Morbelli S, Abruzzese G, Sambuceti G, Rodriguez G.

Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2209-18. doi: 10.1007/s00259-011-1874-1.

0

0

0

PUBMED

Motor imagery ability in patients with early- and mid-stage Parkinson disease.

Heremans E, Feys P, Nieuwboer A, Vercruysse S, Vandenberghe W, Sharma N, Helsen W.

Neurorehabil Neural Repair. 2011 Feb;25(2):168-77. doi: 10.1177/1545968310370750.

0

0

0

PUBMED

Cardiac 123I-MIBG accumulation in Parkinson's disease differs in association with REM sleep behavior disorder.

Miyamoto T, Miyamoto M, Iwanami M, Hirata K.

Parkinsonism Relat Disord. 2011 Mar;17(3):219-20. doi: 10.1016/j.parkreldis.2010.11.020. No abstract available.

0

0

0

PUBMED

The impact of a stress induction task on tic frequencies in youth with Tourette Syndrome.

Conelea CA, Woods DW, Brandt BC.

Behav Res Ther. 2011 Aug;49(8):492-7. doi: 10.1016/j.brat.2011.05.006.

0

0

0

PUBMED

Virtual reality for gait training: can it induce motor learning to enhance complex walking and reduce fall risk in patients with Parkinson's disease?

Mirelman A, Maidan I, Herman T, Deutsch JE, Giladi N, Hausdorff JM.

J Gerontol A Biol Sci Med Sci. 2011 Feb;66(2):234-40. doi: 10.1093/gerona/glq201.

0

0

0

PUBMED

Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.

Foulds PG, Mitchell JD, Parker A, Turner R, Green G, Diggle P, Hasegawa M, Taylor M, Mann D, Allsop D.

FASEB J. 2011 Dec;25(12):4127-37. doi: 10.1096/fj.10-179192.

0

0

0

PUBMED

Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain.

Bøttger P, Tracz Z, Heuck A, Nissen P, Romero-Ramos M, Lykke-Hartmann K.

J Comp Neurol. 2011 Feb 1;519(2):376-404. doi: 10.1002/cne.22524.

0

0

0

PUBMED

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

0

0

0

PUBMED

CAG repeat size in the normal HTT allele and age of onset in Huntington's disease.

Aziz NA, van Roon-Mom WM, Roos RA.

Mov Disord. 2011 Nov;26(13):2450-1; author reply 2451. doi: 10.1002/mds.23849. No abstract available.

0

0

0

PUBMED

Elderly male with progressive dysphagia and ataxia.

Al-Sheikh F.

Neurosciences (Riyadh). 2011 Apr;16(2):172-3. No abstract available.

0

0

0

PUBMED

[Chorea revealing a polycytemia vera].

Ben Ghorbel I, Ben Salem T, Lamloum M, Khanfir M, Braham A, Miled M, Ben Romdhane N, Houman MH.

Rev Med Interne. 2011 Jun;32(6):e79-80. doi: 10.1016/j.revmed.2010.06.015. French.

0

0

0

PUBMED

Gait feature extraction in Parkinson's disease using low-cost accelerometers.

Stamatakis J, Crémers J, Maquet D, Macq B, Garraux G.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7900-3. doi: 10.1109/IEMBS.2011.6091948.

0

0

0

PUBMED

RNA- and DNA- Based Therapies for Huntington’s Disease.

Meghan S, Neil A.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 9.

0

0

0

PUBMED

Anti-glutamic Acid decarboxylase antibody-associated ataxia as an extrahepatic autoimmune manifestation of hepatitis C infection: a case report.

Awad A, Stüve O, Mayo M, Alkawadri R, Estephan B.

Case Rep Neurol Med. 2011;2011:975152. doi: 10.1155/2011/975152.

0

0

0

PUBMED

A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.

Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW; XP053 Study Group..

J Clin Sleep Med. 2011 Jun 15;7(3):282-92. doi: 10.5664/JCSM.1074.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy